European Medicines Agency’s privacy statement for public and targeted consultation

On 14 February 2020 the EMA published its privacy statement for public and targeted consultation.

The European Medicines Agency (hereinafter ‘EMA’ or ‘Agency’) is committed to respecting the right to data protection of the public. The Agency collects and uses personal data in accordance with Regulation (EU) 2018/1725 of the European Parliament and of the Council of 23 October 2018 on the protection of natural persons with regard to the processing of personal data by the Union institutions, bodies, offices and agencies and on the free movement of such data (hereinafter ‘Regulation’).

This privacy statement explains how the Agency collects and uses personal data for purposes related to public and targeted consultations in accordance with the Agency’s data-protection obligations under the Regulation. The launching and management of public consultations by the Agency involves the collection and processing of the personal data of stakeholders, interested parties and individuals who submit their contributions to these consultations. If you fall into one of these categories, it is important that you read and retain this statement, together with any other privacy statements EMA may provide on specific occasions when it is collecting or using personal data about you, so that you are aware of how and why EMA is using such data, and what your rights are under the Regulation.

Read the pdf
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /